Further, plasma kallikrein (antibodies to the beta subunit (KLKB1) were identified) is part of a cascade that results in the activation of bradykinins, which are considered to be potent inflammatory mediators with relevance in arthritis [26]. This evidence concerns the gene KLK4 and arthritic joint disease.